A Phase I, Single center, Open label, Dose De-escalation and Expansion Study of gemcitabine and cisplatin with AG120 or INCB054828 for advanced cholangiocarcinoma

Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma »